More in-depth molecular analysis of the mouse tumors at the genome and proteome level is needed to further understand the underlying mechanism for the enhanced tumor formation by the IGF1 and X10 treatment conditions and their potential role in either enhanced tumor initation and/or progression. This evidence concerns the gene IGF1 and neoplasm.